前收市價 | 11.25 |
開市 | 11.70 |
買盤 | 0.00 |
賣出價 | 0.00 |
拍板 | 57.50 |
到期日 | 2025-01-17 |
今日波幅 | 11.25 - 11.70 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.